- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Active tDCS
Total 564 results
-
University of CadizCompletedPlacebo | Cold-water Immersion | Protein-carbohydrates Supplementation | Active RecoverySpain
-
Yonsei UniversityCompletedActive TuberculosisKorea, Republic of
-
CM Chungmu HospitalUnknownChronic Pain | Elbow Tenderness | Elbow Pain Upon Active Resistive MotionKorea, Republic of
-
Statens Serum InstitutCompletedActive ImmunizationPoland
-
PfizerRecruitingStable Nonsegmental Vitiligo | Active Nonsegmental VitiligoChina, Japan, Canada, Spain, United States, Hungary, Poland, Slovakia
-
AmgenTerminatedActive Systemic Lupus ErythematosusKorea, Republic of, United States, Taiwan, Canada, Spain, Italy, Mexico, Japan, Turkey, Austria, Greece, Colombia, Switzerland, Poland, France, Bulgaria, Hong Kong, Russian Federation, Chile
-
National Institute of Allergy and Infectious Diseases...CompletedHealthy | Stem Cell Transplantation | Active ImmunityUnited States
-
Meir Medical CenterCompletedPost Streptococcal Reactive ArthritisIsrael
-
Brigham and Women's HospitalHarvard Medical School (HMS and HSDM)RecruitingColchicine Mechanism of ActionUnited States
-
University of TorontoHamilton Health Sciences Corporation; Green Shield Canada Inc.; Cookson James...CompletedPhysically Inactive Hospital EmployeesCanada
-
National Institute of Neurological Disorders and...CompletedHealthy | Tactile Spatial AcuityUnited States
-
Vivoryon Therapeutics N.V.CovanceCompletedHealthy Volunteers | Pharmacologic ActionUnited Kingdom
-
Nantes University HospitalTerminatedSerologically Active Adult Systemic Lupus ErythematosusFrance
-
KU LeuvenRecruitingHealthy Controls | IBS | Ulcerative Colitis, Active | Ulcerative Colitis, Remission (3a: With IBS Symptoms, 3b: Without IBS Symptoms) | Crohn's Disease, Active | Crohn's Disease, Remission (6a: With IBS Symptoms, 6b: Without IBS Symptoms)Belgium
-
Alimentiv Inc.TakedaNot yet recruitingCrohn Disease | Moderately to Severely Active Crohn's Disease | Disease Crohn
-
PfizerRecruitingStable Nonsegmental Vitiligo | Active Nonsegmental VitiligoUnited States, Spain, Australia, Mexico, Canada, China, Japan, Italy, Turkey, Korea, Republic of, Germany, South Africa, Poland, United Kingdom, Bulgaria
-
AstraZenecaActive, not recruitingActive Systemic Lupus ErythematosusThailand, Korea, Republic of, Philippines, China, Taiwan, Hong Kong
-
AstraZenecaPRA Health SciencesCompletedActive Systemic Lupus ErythematosusUnited States, France, Germany, Spain, Belgium, Russian Federation, Japan, Korea, Republic of, Argentina, Bulgaria, South Africa, Mexico, Canada, Brazil, Lithuania
-
University Medicine GreifswaldSDI LimitedCompletedDentin Hypersensitivity | Active Dental CariesGermany
-
Christopher O'Brien, MDBioIncept LLCWithdrawnPanel Reactive Antibodies
-
Novartis PharmaceuticalsTerminatedActive DermatomyositisUnited States, Czechia, Japan
-
Balance TherapeuticsCompletedMolecular Mechanisms of Pharmacological ActionUnited Kingdom
-
Teesside UniversityNewcastle UniversityNot yet recruitingMotor Imagery | Action Observation
-
Brown UniversityNational Institute of General Medical Sciences (NIGMS)Recruiting
-
AstraZenecaCompletedHealthy Volunteers | Pharmacologic ActionUnited States
-
Baylor College of MedicineMichael E. DeBakey VA Medical CenterEnrolling by invitationActive C. Difficile ColitisUnited States
-
Novartis PharmaceuticalsWithdrawnActive Peripheral Spondyloarthritis (pSpA)
-
University of RochesterWithdrawnActive Chronic Graft Versus Host DiseaseUnited States
-
Boston UniversityUniversity of Florida; WestatWithdrawnTuberculosis Multi Drug Resistant Active
-
University of HohenheimUniversität TübingenCompletedSafety of Native vs. Micellar 6-PN After Oral Intake | Pharmacokinetics of Native vs. Micellar 6-PN After Oral Intake | PBMC Activity After Native vs. Micellar 6-PN Oral IntakeGermany
-
Sun Pharmaceutical Industries LimitedTerminatedActive Rheumatoid ArthritisBelgium, Netherlands
-
Astellas Pharma IncUCB Japan Co. Ltd.Completed
-
PfizerCompletedActive Rheumatoid Arthritis | Arthritis, Rheumatoid | Rheumatoid ArthritisItaly, Spain, Switzerland, France, Germany, Poland, Netherlands, United Kingdom, Monaco, Romania, Ireland, Qatar, Russian Federation
-
PfizerEmergent Product Development Seattle LLCCompletedActive Rheumatoid ArthritisUnited States, Canada, Serbia, Japan, Spain, Poland, Hungary, Argentina, Chile, Mexico
-
Theodor Bilharz Research InstituteCompletedLack of Drug ActionEgypt
-
Portucalense UniversityUniversity of Coimbra; Aveiro UniversityRecruitingCognitive Dysfunction | Mild Cognitive Impairment | Cognitive Training | tACSPortugal
-
Fundació Institut Germans Trias i PujolNational Center for Tuberculosis and Lung Disease, Tbilisi, GeorgiaUnknownClose Contacts of Active TuberculosisGeorgia
-
University of Alabama at BirminghamWithdrawnDepression | Impulsivity | Active Suicidal IdeationUnited States
-
University Hospital, MontpellierCompletedLatent Tuberculosis | Active TuberculosisFrance
-
University of ValenciaRecruitingMotor Imagery | Therapeutic Exercise | Action ObservationSpain
-
University Hospital of North NorwayNorwegian University of Science and Technology; St. Olavs Hospital; Laval University and other collaboratorsCompletedPhysical Activity Promotion Among Inactive AdultsNorway
-
Zealand University HospitalUniversity of CopenhagenUnknown
-
University of LiverpoolInfectious Diseases Institute, Makerere University College of Health SciencesRecruitingTuberculosis | Breastfeeding | Tuberculosis ActiveUganda
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedActive Rheumatoid ArthritisAustralia, Austria, Belgium, Denmark, Finland, France, Germany, Greece, Israel, Italy, Netherlands, Norway, Poland, Portugal, Romania, Spain, Sweden, United Kingdom, Czechia
-
Tanta UniversityCompleted
-
Eva PharmaDataClinCompletedActive Rheumatoid ArthritisEgypt
-
Atlanta VA Medical CenterWithdrawn
-
Dr. Falk Pharma GmbHCompletedActive Ulcerative ColitisGermany
-
National Taiwan University HospitalUnknownTo Compare the Serum Apoptosis-associated Markers Between Patients With Active TB and Patients With LTBI | To Evaluate the Efficiency of Apoptosis-associated Markers to Differentiate Potential of Active TB From LTBITaiwan
-
Emad Abdel Aal SaliemCompletedPharmacological ActionEgypt